(R,S)-3HPG,
4-hydroxyphenylglycine,
4-hydroxyphenylglycine hydrobromide, (+-)-isomer,
4-hydroxyphenylglycine hydrochloride, (R)-isomer,
4-hydroxyphenylglycine perchlorate, (+-)-isomer,
4-hydroxyphenylglycine, (+-)-isomer,
4-hydroxyphenylglycine, (R)-isomer,
4-hydroxyphenylglycine, (S)-isomer,
4-hydroxyphenylglycine, 2,4-dimethylbenzenesulfonate, (+-)-isomer,
4-hydroxyphenylglycine, 2,4-dimethylbenzenesulfonate, (R)-isomer,
4-hydroxyphenylglycine, 4-methylbenzenesulfonate, (+-)-isomer,
4-hydroxyphenylglycine, 4-methylbenzenesulfonate, (S)-isomer,
4-hydroxyphenylglycine, monosodium salt,
4-hydroxyphenylglycine, monosodium salt, (R)-isomer,
D-p-hydroxyphenylglycine,
L-4-hydroxyphenylglycine,
oxfenicine,
p-hydroxyphenylglycine,
UK 25842,
UK-25842,
22818-40-2,
D-4-Hydroxyphenylglycine,
D(-)-4-Hydroxyphenylglycine,
4-Hydroxy-D-phenylglycine,
D-N-(4-Hydroxyphenyl)glycine,
(R)-2-AMINO-2-(4-HYDROXYPHENYL)ACETIC ACID,
(2R)-2-amino-2-(4-hydroxyphenyl)acetic acid,
H-D-PHG(4-OH)-OH,
D-(-)-4-Hydroxyphenylglycine,
(R)-alpha-Amino-4-hydroxybenzeneacetic acid,
UNII-PCM9OIX717,
MFCD00004262,
(D)-(-)-Alfa-4-hydroxyphenyl glycine,
PCM9OIX717,
(2R)-amino(4-hydroxyphenyl)acetic acid,
D-P-HYDROXYPHENYLGLYCINE,
CHEBI:15695,
Benzeneacetic acid, a-amino-4-hydroxy-, (aR)-,
(2R)-amino(4-hydroxyphenyl)ethanoic acid,
p-hydroxy-D-phenylglycine,
D(-)-4-Hydroxyphenylglycine, 98+%,
4-Hydroxyphenylglycine,
4-Hydroxyphenylglycine, D-(-)-,
EINECS 245-247-7,
PubChem12445,
Cefoperazone Impurity 3,
4-HYDROXY-D-(-)-2-PHENYLGLYCINE,
d-4-hydroxyphenylglicyne,
AC1L3IQU,
Epitope ID:117718,
EC 245-247-7,
P-hydroxy-(R)-phenylglycine,
D-PHG(4-OH)-OH,
KSC550E4H,
SCHEMBL124861,
Benzeneacetic acid, alpha-amino-4-hydroxy-, (alphaR)-,
CTK4F0243,
KS-00000MKN,
LJCWONGJFPCTTL-SSDOTTSWSA-N,
ZINC157101,
4-Hydroxy-D-phenylglycine, >=98%,
ANW-43615,
D-(-)-2-(4-Hydroxyphenyl)glycine,
SBB058359,
(R)-(4-HYDROXYPHENYL)GLYCINE,
AKOS006281607,
AKOS015924172,
AB00341,
AC-1085,
AS06748,
DB04308,
MCULE-7930915902,
RP22994,
RTR-010690,
(R)-2-(4-HYDROXYPHENYL)GLYCINE,
NCGC00164509-02,
(-)-4-Hydroxy-D-phenylglycine, 98+%,
AJ-14884,
AN-15243,
AS-12542,
BC205796,
D-(-)-amino(4-hydroxyphenyl)acetic acid,
SC-10464,
D-2-amino-2-(p-hydroxyphenyl)acetic acid,
D-(-)-2-(P-HYDROXYPHENYL)GLYCINE,
ST2414443,
TR-010690,
(|AR)-|A-Amino-4-hydroxybenzeneacetic acid,
CS-0020117,
FT-0624334,
L-(-)-4-Hydroxy-|A-aminophenylacetic acid,
(R)-Ethyl 2-amino-2-(4-hydroxyphenyl)acetate,
C03493,
(alphaR)-alpha-Amino-4-hydroxybenzeneacetic acid,
818H402,
Z1762997255,
(R)-(-)-2-AMINO-2-(4-HYDROXYPHENYL)ACETIC ACID,
(R)-(-)-ALPHA-AMINO-(4-HYDROXYPHENYL)ACETIC ACID,
UNII-7UYG7X0F53 component LJCWONGJFPCTTL-SSDOTTSWSA-N,
Cefprozil impurity A, European Pharmacopoeia (EP) Reference Standard,
Amoxicillin Related Compound I, United States Pharmacopeia (USP) Reference Standard,
D-alpha-(4-Hydroxy-phenyl)glycine, European Pharmacopoeia (EP) Reference Standard,
OXFENICINE,
Cefadroxil impurity A,
4-Hydroxy-L-phenylglycine,
C8H9NO3,
D-(-)-p-Hydroxyphenylglycine,
C8-H9-N-O3,
CID89853,
ACN-033964,
CS-O-03630,
CS-O-07195,
H0758,
K-6341,
D-(-)-4-Hydroxyphenylglycine, 99% - 25G 25g,
Benzeneacetic acid, .alpha.-amino-4-hydroxy-, (R)-,
D-(-)-4-Hydroxyphenylglycine, 99% - 100G 100g,
Benzeneacetic acid, .alpha.-amino-4-hydroxy-, (.alpha.R)-,
32462-30-9,